 |
Autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19 |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2016-10-14 00:00:00 |
| Sponsor | Novartis Europharm Limited |
